The Oncosearch | Oncotarget

Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling Research Paper

Eisuke Horigome, Michiru Fujieda, Tadashi Handa, Ayaka Katayama, Masashi Ito, Ami Ichihara, Daiki Tanaka, Navchaa Gombodorj, Shinji Yoshiyama, Arito Yamane, Keiichi Yamada, Jun Horiguchi, Kazuo Shinozuka, Tetsunari Oyama, Masahiko Nishiyama, Susumu Rokudai

Published Oct 2, 2018 · Vol. 9, No. 77 · pp. 34554-34566

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study Research Paper

Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Maria Rosaria Valerio, Mario Airoldi, Gabriella Moretti, Corrado Ficorella, Valentina Arcangeli, Lucrezia Diodati, Alberto Zambelli, Antonio Febbraro, Daniele Generali, Mirco Pistelli, Ornella Garrone, Antonino Musolino, Patrizia Vici, Michela Maur, Lucia Mentuccia, Nicla La Verde, Giulia Bianchi, Salvatore Artale, Livio Blasi, Matilde Piezzo, Francesco Atzori, Anna Turletti, Chiara Benedetto, Maria Concetta Cursano, Alessandra Fabi, Vittorio Gebbia, Alessio Schirone, Raffaella Palumbo, Antonella Ferzi, Antonio Frassoldati, Claudio Scavelli, Luca Clivio, Valter Torri on behalf of The EVA Study Group

Published Oct 2, 2018 · Vol. 9, No. 61 · pp. 31877-31887

Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles Research Paper

Takeshi Sawada, Riet Hilhorst, Savithri Rangarajan, Masayuki Yoshida, Yuko Tanabe, Kenji Tamura, Takayuki Kinoshita, Tatsu Shimoyama, Rinie van Beuningen, Rob Ruijtenbeek, Hitoshi Tsuda, Fumiaki Koizumi

Published Sep 28, 2018 · Vol. 9, No. 76 · pp. 34229-34239

The role of AP-1 in self-sufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop Research Paper

Sherif Abd El-Fattah Ibrahim, Aierken Abudu, Eugenia Johnson, Neelum Aftab, Susan Conrad, Michele Fluck

Published Sep 28, 2018 · Vol. 9, No. 76 · pp. 34259-34278

A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells Research Paper

William P. Katt, Nicolas J. Blobel, Svetlana Komarova, Marc A. Antonyak, Ichiro Nakano, Richard A. Cerione

Published Sep 28, 2018 · Vol. 9, No. 76 · pp. 34379-34397

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment Research Paper

David Austin, Nalo Hamilton, Yahya Elshimali, Richard Pietras, Yanyuan Wu, Jaydutt Vadgama

Published Sep 21, 2018 · Vol. 9, No. 74 · pp. 33912-33930

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Mathilde Guerin, Anthony GonÃ§alves, Yves Toiron, Emilie Baudelet, Matthieu Pophillat, Samuel Granjeaud, Patrick Fourquet, William Jacot, Carole Tarpin, Renaud Sabatier, Emilie Agavnian, Pascal Finetti, JosÃ© Adelaide, Daniel Birnbaum, Christophe Ginestier, Emmanuelle Charafe-Jauffret, Patrice Viens, FranÃ§ois Bertucci, Jean-Paul Borg, Luc Camoin

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33762-33777

Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment Research Paper

Concetta Elisa Onesti, Claire Josse, AurÃ©lie Poncin, Pierre FrÃ¨res, Christophe Poulet, Vincent Bours, Guy Jerusalem

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33719-33733

Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline Research Paper

Aldo Germani, Fabio Libi, Stefano Maggi, Gianluca Stanzani, Augusto Lombardi, Patrizia Pellegrini, Mauro Mattei, Laura De Marchis, Claudio Amanti, Antonio Pizzuti, Maria Rosaria Torrisi, Maria Piane

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33648-33655

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line? Editorial

Clinton Yam, Mien-Chie Hung, Gabriel N. Hortobagyi

Published Sep 13, 2018 · Vol. 9, No. 76 · pp. 34193-34195

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction? Editorial

Amelia McCartney, Angelo Di Leo, Luca Malorni

Published Sep 13, 2018 · Vol. 9, No. 75 · pp. 34031-34032

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer Research Paper

Mohamad Elbaz, Dinesh Ahirwar, Zhang Xiaoli, Xinyu Zhou, Maryam Lustberg, Mohd W. Nasser, Konstantin Shilo, Ramesh K. Ganju

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33459-33470

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines Research Paper

Moses Koobotse, Jeff Holly, Claire Perks

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33562-33576

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer Research Paper

Michael J.G. Milevskiy, Gurveen K. Sandhu, Anna Wronski, Darren Korbie, Brooke L. Brewster, Annette Shewan, Stacey L. Edwards, Juliet D. French, Melissa A. Brown

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33577-33588

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Tasaduq H. Wani, Sreeraj Surendran, Vishnu S. Mishra, Jaya Chaturvedi, Goutam Chowdhury, Anindita Chakrabarty

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33589-33600

SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk Research Paper

Masashi Muramatsu, Shin Akakura, Lingqiu Gao, Jennifer Peresie, Benjamin Balderman, Irwin H. Gelman

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33515-33527

Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel Research Paper

Shengwen Calvin Li, Andres Stucky, Xuelian Chen, Mustafa H. Kabeer, William G. Loudon, Ashley S. Plant, Lilibeth Torno, Chaitali S. Nangia, Jin Cai, Gang Zhang, Jiang F. Zhong

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33290-33301

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Research Paper

Chie Kikutake, Minako Yoshihara, Tetsuya Sato, Daisuke Saito, Mikita Suyama

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33337-33347

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling Research Paper

Khalid N. Al-Zahrani, David P. Cook, Barbara C. Vanderhyden, Luc A. Sabourin

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33348-33359

Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib Research Paper

James A. MacLeod, Yan Gao, Christine Hall, William J. Muller, Taranjit S. Gujral, Peter A. Greer

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33382-33395

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling Research Paper

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study Research Paper

Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles Research Paper

The role of AP-1 in self-sufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop Research Paper

A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells Research Paper

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment Research Paper

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment Research Paper

Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline Research Paper

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line? Editorial

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction? Editorial

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer Research Paper

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines Research Paper

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer Research Paper

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk Research Paper

Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel Research Paper

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Research Paper

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling Research Paper

Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling Research Paper

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study Research Paper

Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles Research Paper

The role of AP-1 in self-sufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop Research Paper

A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells Research Paper

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment Research Paper

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment Research Paper

Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline Research Paper

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line? Editorial

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction? Editorial

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer Research Paper

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines Research Paper

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer Research Paper

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk Research Paper

Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel Research Paper

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Research Paper

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling Research Paper

Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib Research Paper